Artelo Biosciences, Inc. (Nasdaq: ARTL) (“Artelo” or the “Company”), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with ...

As cancer care becomes more personalised, nutrition must follow the same path. Ms. Veena V's message is clear: skip the fear-based food rules, nourish the body adequately, and trust evidence over ...

Cancer remains a leading cause of morbidity and mortality, although cancer survivorship has increased impressively in the past decades. Patients with cancer often face cardiovascular complications, ...

New research from the University of Oklahoma, published today in Cancer Cell, describes for the first time a "triangle regulation theory" of cancer-induced cachexia and anorexia. Cachexia is a ...

Immune checkpoint inhibitors (ICIs), including antibodies against the programmed cell death protein 1/ligand 1 (PD-1/L1) effectively at boost the immune system; however, they may cause immune-related ...

Across disciplines, therapeutic areas and even continents, Pfizer scientists have been working to advance understanding of – and potential treatments for – cachexia, a complex metabolic condition ...

Zaver Bhujwalla, vice chair of research and director of the Division of Cancer Imaging Research, has built her career around understanding the tumor microenvironment and developing imaging tools that ...

Cancer dominates the drug development pipeline, but industry has paid little attention over the years to cancer cachexia — the complex weight-loss syndrome that accounts for 20–30% of cancer deaths.

aDepartment of Gastroenterological Surgery, Graduate School of Medicine, The University of Osaka, Suita, Japan bDepartment of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, ...